LONDON (Reuters) - AstraZeneca shares gained 2 percent in early trading on Thursday on speculation that U.S. drugmaker Pfizer was about to return with a higher bid worth more than 53 pounds a share, traders said.
A bid at that level would value Britain's second-biggest pharmaceuticals group at around $113 billion (66.62 billion pounds) .
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!